BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
6 results:

  • 1. TGF-β-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer.
    Zhang F; Yan Y; Cao X; Guo C; Wang K; Lv S
    Cell Death Dis; 2024 Mar; 15(3):218. PubMed ID: 38490994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia.
    Erkeland SJ; Stavast CJ; Schilperoord-Vermeulen J; Dal Collo G; Van de Werken HJG; Leon LG; Van Hoven-Beijen A; Van Zuijen I; Mueller YM; Bindels EM; De Ridder D; Kappers-Klunne MC; Van Lom K; Van der Velden VHJ; Langerak AW
    Haematologica; 2022 Jan; 107(1):143-153. PubMed ID: 33596640
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
    Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
    J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
    Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
    Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
    Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
    Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
    Hejlik DP; Kottickal LV; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian SV; Teng DH; Nagarajan L
    Cancer Res; 1997 Sep; 57(17):3779-83. PubMed ID: 9288787
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.